I
Market Data
$1.33−$0.07 (−5.00%)
INAB · Last trade
Prev Close
$1.40
Range (29d)
$1.33 – $1.48
Recent Filings
- 8-K432.1 KBIN8BIO, INC.Jun 1, 6:56 AM ET·0001193125-26-249684
- 10-Q9.1 MBIN8BIO, INC.May 7, 4:32 PM ET·0001193125-26-212135
- 8-K884.7 KBIN8BIO, INC.May 7, 4:31 PM ET·0001193125-26-212128
- 10-K37.1 MBIN8BIO, INC.Mar 12, 4:15 PM ET·0001193125-26-104181
- 8-K393.9 KBIN8BIO, INC.Mar 12, 4:10 PM ET·0001193125-26-104144
- 8-K139.9 KBIN8BIO, INC.Feb 27, 4:05 PM ET·0001193125-26-082539
- 8-K140.9 KBIN8BIO, INC.Feb 9, 8:31 AM ET·0001193125-26-041975
- 8-K743.6 KBIN8BIO, INC.Dec 19, 5:22 PM ET·0001193125-25-327097
- 8-K143.3 KBIN8BIO, INC.Nov 24, 8:00 AM ET·0001193125-25-292057
- 10-Q9.8 MBIN8BIO, INC.Nov 6, 4:03 PM ET·0001193125-25-269447
Insiders
10- BIOS Advisors GP, LLC10% Owner
- BIOS Capital Management, LP10% Owner
- BIOS Fund II NT, LP10% Owner
- BIOS Fund II QP, LP10% Owner
- BIOS Fund II, LP10% Owner
- BIOS Fund III QP, LP10% Owner
- BIOS Fund III, LP10% Owner
- BP Directors, LP10% Owner
- Beelen MelissaVP, Clinical Operation
- Bios Clinical Opportunity Fund, LP10% Owner
Tickers
Addresses
business
EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330
NEW YORK, NY, 10118
mailing
EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330
NEW YORK, NY, 10118
Former Names
- Incysus Therapeutics, Inc.2018-09-20